- Revenue of €16.1 million
- EBIT of €2.1 million, 13% margin
- Profit after taxes of €3.2 million
- Forecast for fiscal year 2025/2026
- Slight increase in revenue from €17.5 million to €18.0 million
- EBIT between €1.0 million and €1.5 million
Bremen, January 29, 2026 – MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a leading medical imaging software company, announces its results for fiscal year 2024/2025, covering the period from October 1, 2024, to September 30, 2025.
Revenue in the past fiscal year 2024/2025 amounted to €16.1 million (compared to €17.0 million in fiscal year 2023/2024). Of this revenue, 21% (previous year: 25%) was attributable to the sale of licenses, 34% (previous year: 35%) to maintenance revenues and 45% (previous year: 40%) to other revenues, which include, among other things, services for and charges to affiliated companies and the parent company.
EBIT (annual result before profit transfer, interest, and income taxes) fell from €3,500 thousand to €2,137 thousand, mainly due to lower sales revenues compared to the previous year and increased personnel expenses. The EBIT margin fell accordingly from 21% to 13%.
Due to the tax group, only low income taxes of €0.1 million were incurred in the past fiscal year, identical to the previous year.
This results in earnings after taxes of €3,166 thousand (20% margin) for the 2024/2025 fiscal year, compared to €4,561 thousand (27% margin) in 2023/2024. The profit of €3,166 thousand will be transferred to Varex Imaging Deutschland AG on the basis of the control and profit transfer agreement.
After achieving sales revenues of €16.1 million in the 2024/2025 fiscal year, sales are expected to grow slightly in the 2025/2026 fiscal year to between €17.5 million and €18.0 million. In addition to stable sales with the customer Hologic, a slight increase in sales revenue is expected in the lung and liver segment. The addition of MBC KG on November 1, 2025, will also contribute to the expected increase in sales through its sales revenue. In the area of development services, we expect stable performance based on customer contracts and employee planning. In fiscal year 2024/2025, EBIT of €2.1 million was achieved. For the annual result before profit transfer, interest income, and income taxes (EBIT), we expect a result in the 2025/2026 fiscal year of between €1.0 million and €1.5 million, assuming a stable exchange rate of 1.16 USD/EUR. The slight increase in revenue forecast and the simultaneous rise in personnel costs, particularly due to the growth of MBC KG, are the main drivers for the EBIT outlook.
The half-year financial report for the 2025/2026 fiscal year will be published on May 21, 2026.